Rachel Occhiogrosso Abelman (Rachel O Abelman)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Magnetic Resonance

Diffusion Weighted

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Aditya Bardia, Sheng Sun, Nayana Thimmiah, James T T Coates, Bogang Wu, Rachel Occhiogrosso Abelman, Laura M Spring, Beverly Moy, Phoebe Ryan, Mark N Melkonyan, Ann H Partridge, Dejan Juric, Jeffrey M Peppercorn, Heather A Parsons, Seth A Wander, Victoria Attaya, Brenda Lormil, Maria Shellock, Aiko Nagayama, Veerle Bossuyt, Steven Jay Isakoff, Sara M Tolaney, Leif W Ellisen
Antibody Drug Conjugate Sacituzumab Govitecan Enables A Sequential TOP1/PARP Inhibitor Cancer Therapy Strategy in Breast Cancer Patients. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Aditya Bardia, Sheng Sun, Nayana Thimmiah, James T T Coates, Bogang Wu, Rachel Occhiogrosso Abelman, Laura M Spring, Beverly Moy, Phoebe Ryan, Mark N Melkonyan, Ann H Partridge, Dejan Juric, Jeffrey M Peppercorn, Heather A Parsons, Seth A Wander, Victoria Attaya, Brenda Lormil, Maria Shellock, Aiko Nagayama, Veerle Bossuyt, Steven Jay Isakoff, Sara M Tolaney, Leif W Ellisen
Antibody-Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor Therapy Strategy in Patients with Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Aditya Bardia, Sheng Sun, Nayana Thimmiah, James T T Coates, Bogang Wu, Rachel Occhiogrosso Abelman, Laura M Spring, Beverly Moy, Phoebe Ryan, Mark N Melkonyan, Ann H Partridge, Dejan Juric, Jeffrey M Peppercorn, Heather A Parsons, Seth A Wander, Victoria Attaya, Brenda Lormil, Maria Shellock, Aiko Nagayama, Veerle Bossuyt, Steven Jay Isakoff, Sara M Tolaney, Leif W Ellisen
Antibody-Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor Therapy Strategy in Patients with Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Aditya Bardia, Sheng Sun, Nayana Thimmiah, James T T Coates, Bogang Wu, Rachel Occhiogrosso Abelman, Laura M Spring, Beverly Moy, Phoebe Ryan, Mark N Melkonyan, Ann H Partridge, Dejan Juric, Jeffrey M Peppercorn, Heather A Parsons, Seth A Wander, Victoria Attaya, Brenda Lormil, Maria Shellock, Aiko Nagayama, Veerle Bossuyt, Steven Jay Isakoff, Sara M Tolaney, Leif W Ellisen
Antibody-Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor Therapy Strategy in Patients with Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Rachel Occhiogrosso Abelman, Bogang Wu, Laura M Spring, Leif W Ellisen, Aditya Bardia
Mechanisms of Resistance to Antibody-Drug Conjugates. Cancers 15 (4) (2023)
Rachel Occhiogrosso Abelman, Bogang Wu, Laura M Spring, Leif W Ellisen, Aditya Bardia
Mechanisms of Resistance to Antibody-Drug Conjugates. Cancers 15 (4) (2023)
Rachel Occhiogrosso Abelman, Bogang Wu, Laura M Spring, Leif W Ellisen, Aditya Bardia
Mechanisms of Resistance to Antibody-Drug Conjugates. Cancers 15 (4) (2023)